Mesenchymal Stem/Stromal Cells and Their Derived Extracellular Vesicles: a Promising Therapeutic Strategy for Autoimmune Hepatitis
Clinical Reviews in Allergy & Immunology · 10.08.2026 · 69 (1)
DOI: 10.1007/s12016-026-09189-9 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Clinical Reviews in Allergy & Immunology, online erschienen am 10.08.2026. Verfasst von Mai Abdelgawad und 4 weiteren Autor:innen. Beteiligte Einrichtung: John van Geest Centre for Brain Repair, Department of Clinical Neurosciences, University of Cambridge, Cambridge Biomedical Campus, Cambridge, CB2 0P…. Hauptthemen laut MEDLINE: Hepatitis, Autoimmune, Mesenchymal Stem Cells, Extracellular Vesicles, Mesenchymal Stem Cell Transplantation. Die Arbeit nennt 123 Literaturangaben.
Abstract (Originalsprache)
Autoimmune hepatitis (AIH) is an idiopathic autoimmune disorder characterized by chronic liver inflammation that, if untreated, can lead to liver fibrosis and cirrhosis, hepatic failure, and death. Current treatment options for this potentially life-threatening disorder include either high-dose immunosuppressants or liver transplantation (for late-stage patients). However, these options are risky and can lead to long-term complications. Therefore, there is an urgent need to develop novel treatment strategies for AIH. Therapeutic approaches based on mesenchymal stem/stromal cells (MSCs) and their derived extracellular vesicles (EVs) have emerged as a viable treatment option for AIH because of their potent immunomodulatory and anti-inflammatory properties. This review outlines the recent developments in the use of these therapies for the treatment of AIH. The use of EVs as vehicles for the delivery of therapeutic drugs or miRNAs is also discussed. In addition, we discuss the various efforts that have been made to improve the efficacy of such therapies, including their genetic modification and combination with anti-inflammatory drugs. Finally, we proposed several directions for future research aimed at developing MSCs and MSC-derived EVs for clinical applications.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- John van Geest Centre for Brain Repair, Department of Clinical Neurosciences, University of Cambridge, Cambridge Biomedical Campus, Cambridge, CB2 0PY, UK.
- Faculty of Medicine, Tanta University, Tanta, 31512, Egypt.
- University College of Medical Sciences (University of Delhi), Dilshad Garden, Delhi, India.
- Department of Tissue Engineering and Regenerative Medicine, Faculty of Medicine, Universiti Kebangsaan Malaysia, Cheras, Kuala Lumpur, 56000, Malaysia.
- UKM Medical Molecular Biology Institute, Universiti Kebangsaan Malaysia, Cheras, Kuala Lumpur, 56000, Malaysia. sctan@ukm.edu.my.
Zitieren
APA
Abdelgawad, M., Allam, S., Javed, A., Law, J. X., & Tan, S. C. (2026). Mesenchymal Stem/Stromal Cells and Their Derived Extracellular Vesicles: a Promising Therapeutic Strategy for Autoimmune Hepatitis. Clinical Reviews in Allergy & Immunology, 69(1). https://doi.org/10.1007/s12016-026-09189-9
Vancouver
Abdelgawad M, Allam S, Javed A, Law JX, Tan SC. Mesenchymal Stem/Stromal Cells and Their Derived Extracellular Vesicles: a Promising Therapeutic Strategy for Autoimmune Hepatitis. Clinical Reviews in Allergy & Immunology. 2026;69(1). doi:10.1007/s12016-026-09189-9
BibTeX
@article{Abdelgawad2026,
author = {Abdelgawad, Mai and Allam, Sahar and Javed, Amaan and Law, Jia Xian and Tan, Shing Cheng},
title = {Mesenchymal Stem/Stromal Cells and Their Derived Extracellular Vesicles: a Promising Therapeutic Strategy for Autoimmune Hepatitis},
journal = {Clinical Reviews in Allergy & Immunology},
year = {2026},
volume = {69},
number = {1},
doi = {10.1007/s12016-026-09189-9}
}
EUVIMED